plans to expand its manufacturing busines and also expand its presence in international markets, especially Indonesia, says its acting managing director Mohamed Iqbal Abdul Rahman.
In a statement issued aftet its AGM on Tuesday, he said many of its shareholders were keen to find out more about its Halal vaccine project, which includes the Covid-19 fill and finish.
“We will be making a separate announcement on this matter once we have firmed up the relevant details.
“Moving forward, we are projecting improved results in the coming years, particularly given the fact that we were able to complete the accelerated amortisation of PhIS in 2019, ” he added.
Mohamed Iqbal said in managing the impact of the Covid-19 pandemic, the group had adapted to the new normal and have improved its standard operating procedures.
He said these measures were to ensure the safety of its human capital as well as the continuity of its business operations.
“While there are undoubtedly challenges ahead for the group, we are confident in our ability to capitalise on viable opportunities in the healthcare sector to achieve sustainable growth over the long-term and enhance value for our shareholders, ” he added.
Meanwhile, Pharmaniaga chairman Datuk Dr Hafsah Hashim said the board was able to have interacted with so many of its shareholders virtually, in keeping with its commitment to adapt to the new normal and observe Covid-19 preventive measures, to ensure the health and safety of our shareholders.
He added the interactive session saw all resolutions being passed.
BR 24130 
US 11304 
AR 2995 
AO 2790 
MY 2260 
DE 2187 
EC 1435 
TH 782 
